Ursodiol - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for ursodiol and what is the scope of freedom to operate?
Ursodiol
is the generic ingredient in four branded drugs marketed by Teva Branded Pharm, Abhai Llc, Amneal Pharms Co, Aurobindo Pharma Ltd, Chartwell Rx, Epic Pharma, Hibrow Hlthcare, Impax Labs Inc, Lannett Co Inc, Lgm Pharma, Norvium Bioscience, Rising, Rk Pharma, Strides Pharma, Teva Pharms, Zydus Lifesciences, Allergan, Endo Operations, Epic Pharma Llc, Glenmark Pharms Ltd, and Teva Pharms Usa, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.There are eight drug master file entries for ursodiol. Thirty suppliers are listed for this compound.
Summary for ursodiol
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 21 |
NDAs: | 24 |
Drug Master File Entries: | 8 |
Finished Product Suppliers / Packagers: | 30 |
Raw Ingredient (Bulk) Api Vendors: | 93 |
Clinical Trials: | 38 |
Patent Applications: | 6,397 |
Drug Prices: | Drug price trends for ursodiol |
Drug Sales Revenues: | Drug sales revenues for ursodiol |
What excipients (inactive ingredients) are in ursodiol? | ursodiol excipients list |
DailyMed Link: | ursodiol at DailyMed |
Recent Clinical Trials for ursodiol
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Asmaa Abdelfattah Elsayed | Phase 4 |
University of Minnesota - Clinical and Translational Science Institute | Phase 1 |
University of Minnesota | Phase 1 |
Pharmacology for ursodiol
Drug Class | Bile Acid |
US Patents and Regulatory Information for ursodiol
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zydus Lifesciences | URSODIOL | ursodiol | TABLET;ORAL | 211145-001 | Oct 30, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Norvium Bioscience | URSODIOL | ursodiol | CAPSULE;ORAL | 090530-001 | Feb 17, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Epic Pharma Llc | URSODIOL | ursodiol | TABLET;ORAL | 214717-001 | Aug 14, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ursodiol
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | URSO 250 | ursodiol | TABLET;ORAL | 020675-001 | Dec 10, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | URSO FORTE | ursodiol | TABLET;ORAL | 020675-002 | Jul 21, 2004 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.